Early Renoprotective Effect of Ruxolitinib in a Rat Model of Diabetic Nephropathy.

Pharmaceuticals (Basel) · 2021 · PMC8308627 · PMID 34202668

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

A high dose of ruxolitinib showed a trend toward a reduction of IL-1β, though statistically insignificant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.